The association between the triglyceride-glucose index and diabetic peripheral neuropathy: a systematic review and meta-analysis
Authors:
Open Access
- 4 September 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1901899
Abstract
Background: Diabetic peripheral neuropathy (DPN) is a prevalent and severe microvascular complication of type 2 diabetes mellitus (T2DM). Early risk screening and warning are critical for slowing disease progression. The triglyceride-glucose (TyG) index, a simple and efficient surrogate marker for assessing insulin resistance (IR), has been proven to be closely associated with various diabetic complications. However, existing studies on the association between the TyG index and the risk of DPN have yielded inconsistent findings, and relevant evidence still lacks systematic synthesis. Methods: A systematic review and meta-analysis were conducted. We systematically searched databases including PubMed, Embase, Web of Science, CNKI, Wanfang, and CQVIP to enroll observational studies exploring the association between the TyG index and the risk of DPN in patients with T2DM. Two investigators independently performed literature screening, data extraction, and quality assessment. The random-effects and fixed-effects models were applied to pool effect sizes, and subgroup analyses were carried out to explore potential sources of heterogeneity. Results: A total of 14 studies involving 32,281 participants were included. The results showed that a higher TyG index was associated with an increased risk of DPN, with a pooled odds ratio (OR) of 2.614 (95% CI: 1.788-3.821, P < 0.0001) and a pooled hazard ratio (HR) of 1.248 (95% CI: 1.003-1.553, P = 0.0471). This positive correlation remained consistent across most subgroups stratified by age, sample size, BMI, and adjustment for confounding factors. However, the association did not reach statistical significance in the non-China subgroup. Conclusion: Elevated TyG levels are associated with an increased risk of DPN in patients with T2DM. However, the causal relationship requires further validation. These findings may serve as a reference for clinical screening of DPN risk. Systematic Review Registration: https://www.crd.york.ac.uk/prospero , identifier CRD420261373476.Keywords
This publication has 73 references indexed in Scilit:
- Impact of baseline and trajectory of the cardiometabolic indices on incident microvascular complications in patients with type 2 diabetesAtherosclerosis, 2025
- Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R SignalingJournal of Neuroimmune Pharmacology, 2025
- Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathyEndocrine, 2024
- Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 DiabetesDiabetes Therapy, 2024
- The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indicesJournal of Endocrinological Investigation, 2023
- Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathyDiabetologia, 2022
- Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)Diabetes/Metabolism Research and Reviews, 2020
- Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologistsClinical Neurophysiology, 2018
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985